Hormone Inhibin A

Content provided by Healthwise

Test Overview

The inhibin A test is done to measure the amount of this hormone in a pregnant woman's blood to see if the baby may have Down syndrome. Inhibin A is made by the placenta during pregnancy.

The level of inhibin A in the blood is used in a maternal serum quadruple screening test. Generally done between 15 and 20 weeks, this test checks the levels of four substances in a pregnant woman's blood. The quad screen checks alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), a type of estrogen (unconjugated estriol, or uE3), and the hormone inhibin A. The levels of these substances—along with a woman's age and other factors—help the doctor estimate the chance that the baby may have certain problems or birth defects.

In some cases a combination of screening tests is done in the first trimester to look for Down syndrome. This screening test uses an ultrasound measurement of the thickness of the skin at the back of the fetus's neck (nuchal translucency), plus a blood test of the levels of the pregnancy hormone hCG and a protein called pregnancy-associated plasma protein A (PAPP-A). This test is about as accurate as the second-trimester maternal serum quad screening.¹

Should I have the maternal serum screening test (quad screen)?

Last updated:	May 14, 2008
Author:	Sandy Jocoy, RN
Reviewed By:	Sarah Marshall, MD - Family Medicine, Siobhan M. Dolan, MD, MPH - Reproductive Genetics
Editors:	Kathleen M. Ariss, MS, Tracy Landauer